Urolithiasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For Groups 1 and 2 • Age 20 to 70 years • Male or Female • Diagnosed with urolithiasis at the Urological and General Surgical Units (defined and confirmed by the imaging studies) For Groups 3 and 4 • Age 20 to 70 years • Male or Female • Patients without urolithiasis (negative imaging studies)
Exclusion criteria
Exclusion criteria: • Patients with major illnesses such as renal failure, acute infections including acute urinary tract infections (eg: payelonephritis), carcinoma, diabetes mellitus • Unstable patients (Patients who are unstable mentally (patients with psychiatric disorders and dementia) or physically (bedridden patients)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Urine leukocytes, erythrocytes, nitrite and protein to exclude the presence of urinary tract infection (at baseline only) using the Dipstick test [At the baseline and at 15th day after the commencement of the intervention ] 2. Urine pH by using pH meter [At the baseline and at 15th day after the commencement of the intervention ] 3. Specific gravity by the urine strip test [At the baseline and at 15th day after the commencement of the intervention ] 4. Citrate, tartaric acid (tartrate), uric acid, oxalate, creatinine, phosphorus in urine using the spectrophotometric assay kits. [At the baseline and at 15th day after the commencement of the intervention ] 5. Presence of urinary crystals will be examined by light microscopic methods [At the baseline and at 15th day after the commencement of the intervention ] 6. Sodium, potassium in urine will be estimated by Ion Selective Electrode automated analyzers [At the baseline and at 15th day after the commencement of the intervention ] 7. Ionized calcium (or total calcium + albumin), magnesium, citrate, tartaric acid (tartrate), uric acid, oxalate, creatinine, phosphorus in serum using spectrophotometric assay kits. [At the baseline and at 15th day after the commencement of the intervention ] 8. Sodium, potassium in serum will be estimated by Ion Selective Electrode automated analyzers [At the baseline and at 15th day after the commencement of the intervention ] | — |
Secondary
| Measure | Time frame |
|---|---|
| None [] | — |
Countries
Sri Lanka
Contacts
Senior Lecturer